Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans
Article in Cell Death Discovery (May 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in Cell Death Discovery (May 2024)
Preprint in bioRxiv (April 2024)
Article in Frontiers in Oncology (March 2024)